• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猴眼视网膜下新生血管的光动力疗法。

Photodynamic therapy of subretinal neovascularization in the monkey eye.

作者信息

Miller H, Miller B

机构信息

Department of Ophthalmology, Rambam Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa.

出版信息

Arch Ophthalmol. 1993 Jun;111(6):855-60. doi: 10.1001/archopht.1993.01090060145039.

DOI:10.1001/archopht.1993.01090060145039
PMID:8512490
Abstract

Experimental subretinal neovascularization in the monkey eye was treated by photodynamic therapy with rose bengal. Following intravenous injection of rose bengal, the subretinal vessels were irradiated with filtered light. Successful treatment was achieved, provided the subretinal vessels were irradiated during the period in which the dye was present in and around the subretinal vessels but had already cleared from the retinal vasculature. The successfully treated lesions demonstrated replacement of the leaking and pooling subretinal vessels with a non-leaky scar. Morphologic evaluation revealed immediate destruction of the subretinal plexus, with minimal damage to the overlying retina. The destroyed subretinal tuft was replaced by a scar containing mainly fibroblasts embedded in collagen fibers. Our results suggest that photodynamic therapy is potentially useful for destruction of subretinal vessels without damaging the overlying retina.

摘要

用孟加拉玫瑰红进行光动力疗法治疗猴眼实验性视网膜下新生血管。静脉注射孟加拉玫瑰红后,用滤光对视网膜下血管进行照射。如果在染料存在于视网膜下血管及其周围但已从视网膜血管系统清除的期间对视网膜下血管进行照射,就能成功实现治疗。成功治疗的病变显示,渗漏和积血的视网膜下血管被无渗漏的瘢痕所取代。形态学评估显示视网膜下丛立即被破坏,而上方视网膜受损极小。被破坏的视网膜下丛被主要由嵌入胶原纤维的成纤维细胞组成的瘢痕所取代。我们的结果表明,光动力疗法在不损伤上方视网膜的情况下,对破坏视网膜下血管可能是有用的。

相似文献

1
Photodynamic therapy of subretinal neovascularization in the monkey eye.猴眼视网膜下新生血管的光动力疗法。
Arch Ophthalmol. 1993 Jun;111(6):855-60. doi: 10.1001/archopht.1993.01090060145039.
2
Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.2A型特发性黄斑旁视网膜毛细血管扩张症视网膜下新生血管膜的光动力疗法
Am J Ophthalmol. 2002 Jan;133(1):149-51. doi: 10.1016/s0002-9394(01)01205-3.
3
[Selective occlusion of subretinal neovascularization with photodynamic therapy].[光动力疗法选择性封闭视网膜下新生血管]
Ophthalmologe. 1994 Dec;91(6):789-95.
4
Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy.镥特沙卟啉(Lu-Tex):一种用于眼底血管造影和光动力疗法的潜在新型药物。
Am J Ophthalmol. 2000 Mar;129(3):353-62. doi: 10.1016/s0002-9394(99)00462-6.
5
Pathogenesis of laser-induced choroidal subretinal neovascularization.激光诱导脉络膜视网膜下新生血管形成的发病机制。
Invest Ophthalmol Vis Sci. 1990 May;31(5):899-908.
6
Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
Arch Ophthalmol. 1995 Jun;113(6):810-8. doi: 10.1001/archopht.1995.01100060136048.
7
Treatment of experimental preretinal neovascularization using photodynamic thrombosis.运用光动力血栓形成法治疗实验性视网膜前新生血管形成
Invest Ophthalmol Vis Sci. 1991 Aug;32(9):2530-5.
8
[Clinical notes during photodynamic therapy for subretinal neovascularization].
Vestn Oftalmol. 2007 Nov-Dec;123(6):43-6.
9
Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.光动力疗法联合玻璃体内注射曲安奈德治疗双侧特发性黄斑旁毛细血管扩张症的视网膜下新生血管
Am J Ophthalmol. 2004 Nov;138(5):884-5. doi: 10.1016/j.ajo.2004.05.073.
10
Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization.
Am J Ophthalmol. 2004 Nov;138(5):892-4. doi: 10.1016/j.ajo.2004.06.010.

引用本文的文献

1
Large animal models for investigating the applications of photodynamic therapy.用于研究光动力疗法应用的大型动物模型。
Zool Res. 2025 May 18;46(3):551-575. doi: 10.24272/j.issn.2095-8137.2024.445.
2
Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases.多功能纳米微纳递药系统用于眼底新生血管疾病的靶向治疗。
J Nanobiotechnology. 2024 Jun 20;22(1):354. doi: 10.1186/s12951-024-02614-1.
3
Lack of a timing system in the old but still new theory: towards elucidating schizophrenia.
旧但仍新颖的理论中缺乏时间系统:迈向阐明精神分裂症
Gen Psychiatr. 2022 Dec 29;35(6):e100842. doi: 10.1136/gpsych-2022-100842. eCollection 2022.
4
Improvement and optimization of standards for a preclinical animal test model of laser induced choroidal neovascularization.激光诱导脉络膜新生血管形成的临床前动物试验模型标准的改进与优化
PLoS One. 2014 Apr 29;9(4):e94743. doi: 10.1371/journal.pone.0094743. eCollection 2014.
5
Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).用于年龄相关性黄斑变性的高辐照度与光动力疗法(一篇美国眼科学会论文)
Trans Am Ophthalmol Soc. 2008;106:357-82.
6
Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.在鸡胚绒毛尿囊膜(CAM)模型中,使用维替泊芬(Visudyne)进行光动力疗法诱导新生血管闭塞的视频监测。
Angiogenesis. 2008;11(3):235-43. doi: 10.1007/s10456-008-9106-4. Epub 2008 Mar 7.
7
Ophthalmic light sensitive nanocarrier systems.眼科光敏纳米载体系统
Drug Discov Today. 2008 Feb;13(3-4):124-34. doi: 10.1016/j.drudis.2007.12.005. Epub 2008 Feb 1.
8
Photodynamic therapy for choroidal neovascularization. The Jules Gonin Lecture, Montreux, Switzerland, 1 September 2002.
Graefes Arch Clin Exp Ophthalmol. 2003 Apr;241(4):258-62. doi: 10.1007/s00417-003-0623-y. Epub 2003 Mar 11.
9
Vascular endothelial growth factor and ocular neovascularization.血管内皮生长因子与眼部新生血管形成
Am J Pathol. 1997 Jul;151(1):13-23.
10
Feasibility of laser targeted photo-occlusion of ocular vessels.眼部血管激光靶向光凝术的可行性。
Br J Ophthalmol. 1995 Aug;79(8):766-70. doi: 10.1136/bjo.79.8.766.